Saharsh Davuluri, Neuland Labs, urges API and peptide automation by 2026 to match modern biologics standards.

Amid shortages of cancer drugs in the U.S., the API Innovation Center will use continuous manufacturing technology and a partnership with Apertus Pharmaceuticals and the Glioblastoma Foundation to ...

Technological innovations throughout the past several decades have transformed the pharmaceutical manufacturing process from traditional batch production to ...

Eli Lilly and Company (Lilly) plans to construct an active pharmaceutical ingredient (API) manufacturing facility, totaling around 1 million square feet, in Harris County, Texas. According to news ...

ST. LOUIS--(BUSINESS WIRE)--The API Innovation Center (APIIC) today announced that it has been awarded funding by the Administration for Strategic Preparedness and Response’s (ASPR) Center for ...

—The Noramco Group Addresses Critical Supply Chain Challenges, Offering Comprehensive Active Pharmaceutical Ingredients (API) and Drug Product Solutions— WILMINGTON, Del.--(BUSINESS WIRE)--Noramco, a ...

As a newly christened manufacturing facility comes online in one part of Ireland, Merck KGaA plans to turn out the lights at another roughly three hours north. Merck KGaA plans to discontinue ...

Flow Chemistry continues to gain momentum as a powerful alternative to batch processing, offering improved safety, easier ...

Process development is the exercise of creating new and improved manufacturing methods, optimizing them in terms of time and financial efficiency while maintaining regulatory compliance and product ...

Even when a drug finishes its production in the U.S., its active and inactive components often come from overseas. While pharmaceutical companies have been unveiling plans for new U.S. manufacturing ...

An active pharmaceutical ingredients (API) manufacturing facility of Aurobindo Pharma subsidiary Apitoria Pharma in Hyderabad has received three observations from the U.S. Food and Drug Administration ...

Sudarshan Pharma Industries Ltd (SPIL), a key Indian player in pharmaceutical manufacturing and distribution, has been officially recognised as a One Star Export House by the Directorate General of ...